Home » Topics » Regulatory » Patents

Patents
RSS

Immunosuppressants discovered by Merck & Co.

Feb. 18, 1997

Abbott discloses nicotinic cholinergic channel modulators

Feb. 18, 1997

Adenosine kinase inhibitors prepared by Gensia

Feb. 18, 1997

Ortho synthesizes inhibitors of serine proteases

Feb. 18, 1997

COR Therapeutics discloses factor Xa inhibitors

Feb. 18, 1997

Apoptosis-regulating factor discovered

Feb. 17, 1997

Chiron prepares uPA inhibitors

Feb. 17, 1997

Human Genome Sciences discloses novel human polypeptide for cancer

Feb. 17, 1997

BASF focuses on dolastatin derivatives

Feb. 17, 1997

Novel anti-HIV compounds disclosed by Novartis

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...